Fact CheckerSign in

NCT05841797Completed

Evaluation of Problem Management Plus in Pregnant Women With HIV in Kenya

Piloting Risk Stratification and Tailored Interventions With Pregnant and Postpartum Women With HIV in Kenya to Prevent Disengagement From Care and Viral Failure

Source: ClinicalTrials.gov · Last updated 5 Dec 2025

Brief summary (registry, in English)

This study includes secondary quantitative analysis, qualitative methods, and hybrid type 2 implementation-effectiveness pilot trial. The overall goal of this protocol is to determine whether risk stratification of PWLWH in conjunction with a tailored psychosocial support intervention can optimize health outcomes for the vulnerable women and infants. This study will be conducted in high-volume, low-resource health facilities in Kisumu County, Kenya, which is a priority area for research among WLWH and one of the highest HIV burden counties.

Status (registry)
Completed
Study type
Interventional
Enrollment
120 (actual)
First submitted
4 Apr 2023
Start date
5 Jun 2023
Primary completion date
12 Aug 2025
Lead sponsor
University of Colorado, Denver
Diseases
HIV
NCT number
NCT05841797

What you commit to

  • Study type: Interventional
  • Participants enrolled: 120
  • From 5 Jun 2023 to the primary completion date, 12 Aug 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Imminent plans of suicide and severe impairment due to severe mental, neurological or substance use disorders

Lab values

  • Not HIV-infected at time of first ANC visit

Age

  • Less than 15 years of age
  • Less than 20 weeks estimated gestational age or not currently pregnant

Who the study is looking for

  • Pregnant woman living with HIV attending an ANC clinic in Kisumu County, on/initiating ART
  • At least 15 years of age
  • At least 20 weeks estimated gestational age
  • At moderate or critical risk of the combined outcome of treatment disengagement or viral failure according to the risk calculator
  • Access to a cell phone (for those who share phones, have disclosed their HIV status to whomever individuals share the phone with.

Age in the registry: 15 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Kenya Medical Research Institute
Coordinator of this site? Confirm its status
NairobiKenyaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.